Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06963476 · ClinicalTrials.gov registry record · NA

rTMS as Add on Treatment for Substance Use Disorders

A NA study of Alcohol Use Disorder and Opioid Use, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06963476 is a NA study of Alcohol Use Disorder and Opioid Use that is actively recruiting participants, run by Yale University. The registered enrollment target is 80 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06963476, a NA study of Alcohol Use Disorder and Opioid Use, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This pilot study is designed to test feasibility and superiority of rTMS types and target locations for the optimal rTMS intervention for individuals seeking treatment for Alcohol Use Disorder (AUD) or Opioid Use Disorder (OUD). The critical questions this study seeks to answer are: which rTMS type applied to l-dlPFC in OUD participants will induce the greatest reduction of opioid use post-treatment? Is inhibitory rTMS applied to medial prefrontal cortex (mPFC) more effective than excitatory rTMS applied to l-dlPFC at reducing alcohol use post treatment in AUD participants?

Conditions Studied

Alcohol Use Disorder Opioid Use

Interventions

  • DEVICE repetitive transcranial magnetic stimulation (rTMS) for AUD
  • DEVICE repetitive transcranial magnetic stimulation (rTMS) for OUD

Study Locations (1)

Connecticut

  • Hartford Healthcare - Hartford

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-05-12
Est. Completion 2026-05
Phase NA

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06963476

The ClinicalTrials.gov registry entry for NCT06963476 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (76% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which repetitive transcranial magnetic stimulation (rTMS) for AUD is the first listed.

NCT06963476 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT06963476 about?

NCT06963476 is a clinical study titled "rTMS as Add on Treatment for Substance Use Disorders". This pilot study is designed to test feasibility and superiority of rTMS types and target locations for the optimal rTMS intervention for individuals seeking treatment for Alcohol Use Disorder (AUD) or Opioid Use Disorder (OUD). The critical questions this study seeks to answer are: which rTMS type...

What is the current status of trial NCT06963476?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-05-12. Estimated completion is 2026-05.

What conditions does trial NCT06963476 study?

This clinical trial studies the following conditions: Alcohol Use Disorder, Opioid Use.

What interventions are being tested in trial NCT06963476?

The interventions under investigation include: repetitive transcranial magnetic stimulation (rTMS) for AUD (DEVICE), repetitive transcranial magnetic stimulation (rTMS) for OUD (DEVICE).

Who is sponsoring clinical trial NCT06963476?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06963476 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alcohol Use Disorder

All registered trials for this condition

Opioid Use

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.